TOKYO -- The global electric vehicle boom threatens to exacerbate shortages of cheap but lifesaving drugs in Japan as soaring demand for EV battery materials like lithium pushes prices of key ingredients higher.
Drugmaker Mitsubishi Tanabe to stop making lithium tablets due to shortage risk
Lithium is a key ingredient in medicines used to treat bipolar disorder as well as to make batteries for electric vehicles. © Reuters
TOKYO -- The global electric vehicle boom threatens to exacerbate shortages of cheap but lifesaving drugs in Japan as soaring demand for EV battery materials like lithium pushes prices of key ingredients higher.